Evidence map›Paper›PMID 36500603›Full record

ArticleMolecules (Basel, Switzerland)2022

Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells.

Andrea Ianni, Pierdomenico Ruggeri, Pierangelo Bellio, Francesco Martino, Giuseppe Celenza, Giuseppe Martino, Nicola Franceschini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrea IanniDepartment of BioScience and Technology for Food, Agriculture and Environment, University of Teramo, Via Renato Balzarini 1, 64100 Teramo, Italy.ORCID 0000-0003-3102-6804
Pierdomenico RuggeriDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, 67100 L'Aquila, Italy.
Pierangelo BellioDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, 67100 L'Aquila, Italy.ORCID 0000-0001-6488-8027
Francesco MartinoDepartment of Cardiovascular, Respiratory, Nephrological, Anaesthetic and Geriatric Sciences, "La Sapienza" University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
Giuseppe CelenzaDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, 67100 L'Aquila, Italy.
Giuseppe MartinoDepartment of BioScience and Technology for Food, Agriculture and Environment, University of Teramo, Via Renato Balzarini 1, 64100 Teramo, Italy.ORCID 0000-0002-7878-9318
Nicola FranceschiniDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, 67100 L'Aquila, Italy.
University of L'Aquila · ITUniversity of Teramo · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvianolic acid B (SalB) is a bioactive compound from

Indexed as

Breast NeoplasmsMatrix Metalloproteinase 9BenzofuransDepsidesFemaleHumansMolecular Docking SimulationNeoplasm InvasivenessZincBenzofuransDepsidesMatrix Metalloproteinase 9salvianolic acid BZincgelatinase Bmatrix metalloproteinase 9MDA-MB-231 human breast cancer cellsSalvianolic acid BTIMP-1

Identifiers

PMID36500603
PMCPMC9740829
OpenAlexW4310742036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.